Targeting inflammaging through glycomics Longevity technology is Daily news and insights on the fast-growth longevity market, here are articles about Targeting inflammaging through glycomics. Click here to read the article.
Introduction to Avenna In this video, we explain how our in-vitro diagnostic platform technology- GlyHealth can enhance healthcare for chronic inflammatory diseases. We explain the benefits of our biomarkers for different members of healthcare ecosystem, including clinicians and drug development companies. BACK TO MEDIA GALLERY